Marie Linder

1.7k total citations
72 papers, 1.2k citations indexed

About

Marie Linder is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Hematology. According to data from OpenAlex, Marie Linder has authored 72 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 11 papers in Surgery and 11 papers in Hematology. Recurrent topics in Marie Linder's work include Platelet Disorders and Treatments (10 papers), Atrial Fibrillation Management and Outcomes (8 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Marie Linder is often cited by papers focused on Platelet Disorders and Treatments (10 papers), Atrial Fibrillation Management and Outcomes (8 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Marie Linder collaborates with scholars based in Sweden, Denmark and United States. Marie Linder's co-authors include Rolf Sundberg, Helle Kieler, Fredrik Granath, Shahram Bahmanyar, Maria Elmberg, Olof Stephansson, Gabriella Bröms, Morten Andersen, Laura Pazzagli and Fredrik Nyberg and has published in prestigious journals such as Blood, Gastroenterology and PLoS ONE.

In The Last Decade

Marie Linder

67 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marie Linder Sweden 16 214 209 202 196 139 72 1.2k
Stein Bergan Norway 26 324 1.5× 469 2.2× 29 0.1× 209 1.1× 246 1.8× 106 2.1k
Masayuki Hashiguchi Japan 16 115 0.5× 110 0.5× 29 0.1× 45 0.2× 151 1.1× 64 936
S. E. Tett Australia 20 138 0.6× 71 0.3× 47 0.2× 47 0.2× 138 1.0× 51 1.2k
Sarah Clarke United Kingdom 20 95 0.4× 581 2.8× 58 0.3× 63 0.3× 956 6.9× 47 2.6k
Christian Laveille France 14 47 0.2× 117 0.6× 28 0.1× 118 0.6× 120 0.9× 33 1.0k
MO Karlsson Sweden 17 78 0.4× 81 0.4× 36 0.2× 68 0.3× 203 1.5× 29 1.2k
Xinqi Cheng China 21 119 0.6× 177 0.8× 15 0.1× 37 0.2× 240 1.7× 113 1.5k
Wooseong Huh South Korea 26 142 0.7× 524 2.5× 26 0.1× 108 0.6× 448 3.2× 178 2.5k
Federica Braga Italy 29 119 0.6× 407 1.9× 11 0.1× 130 0.7× 264 1.9× 63 2.2k
Simon de Denus Canada 24 73 0.3× 383 1.8× 36 0.2× 70 0.4× 130 0.9× 96 1.9k

Countries citing papers authored by Marie Linder

Since Specialization
Citations

This map shows the geographic impact of Marie Linder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Linder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Linder more than expected).

Fields of papers citing papers by Marie Linder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Linder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Linder. The network helps show where Marie Linder may publish in the future.

Co-authorship network of co-authors of Marie Linder

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Linder. A scholar is included among the top collaborators of Marie Linder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Linder. Marie Linder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bröms, Gabriella, Anders Forss, Johan Askling, et al.. (2025). Adult-onset inflammatory bowel disease and the risk of venous thromboembolism – a Swedish nationwide cohort study 2007–2021. Scandinavian Journal of Gastroenterology. 60(6). 526–535.
2.
Pazzagli, Laura, et al.. (2024). Consistency between the National Patient Register and the Swedish Cancer Register. Pharmacoepidemiology and Drug Safety. 33(4). e5780–e5780.
3.
Linder, Marie, Anders Ekbom, Gunnar Brobert, et al.. (2024). Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study. Journal of Thrombosis and Thrombolysis. 57(6). 973–983. 1 indexed citations
4.
Linder, Marie, et al.. (2023). A global systematic overview of socioeconomic factors associated with antidiabetic medication adherence in individuals with type 2 diabetes. Journal of Health Population and Nutrition. 42(1). 122–122. 15 indexed citations
5.
Kildegaard, Helene, Lotte Rasmussen, Kari Furu, et al.. (2021). Use of non‐insulin antidiabetic drugs in children and young adults – A Scandinavian drug utilization study from 2010–2019. British Journal of Clinical Pharmacology. 87(11). 4470–4475. 2 indexed citations
6.
McGrath, Leah J., Carrie M. Nielson, Bradley Saul, et al.. (2021). Lessons Learned Using Real‐World Data to Emulate Randomized Trials: A Case Study of Treatment Effectiveness for Newly Diagnosed Immune Thrombocytopenia. Clinical Pharmacology & Therapeutics. 110(6). 1570–1578. 4 indexed citations
7.
Phiri, Kelesitse, Jesper Hallas, Marie Linder, et al.. (2021). A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder. Current Medical Research and Opinion. 37(5). 867–877. 2 indexed citations
8.
Ekstrand, Charlotta, Shahram Bahmanyar, Honar Cherif, Helle Kieler, & Marie Linder. (2020). Cancer risk in patients with primary immune thrombocytopenia – A Swedish nationwide register study. Cancer Epidemiology. 69. 101806–101806. 7 indexed citations
9.
Ekstrand, Charlotta, Marie Linder, Bérangère Baricault, et al.. (2019). Impact of risk factors on the occurrence of arterial thrombosis and venous thromboembolism in adults with primary immune thrombocytopenia – Results from two nationwide cohorts. Thrombosis Research. 178. 124–131. 24 indexed citations
10.
Margulis, Andrea V., Marie Linder, Alejandro Arana, et al.. (2018). Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom. PLoS ONE. 13(9). e0204456–e0204456. 15 indexed citations
11.
12.
13.
Castellsagué, Jordi, Brian Calingaert, Beatriz Poblador‐Plou, et al.. (2016). Characterization of new users of cilostazol in the United Kingdom, Spain, Sweden, and Germany. Pharmacoepidemiology and Drug Safety. 25. 203–204. 1 indexed citations
14.
Ekstrand, Charlotta, Marie Linder, Honar Cherif, Helle Kieler, & Shahram Bahmanyar. (2016). Increased susceptibility to infections before the diagnosis of immune thrombocytopenia. Journal of Thrombosis and Haemostasis. 14(4). 807–814. 20 indexed citations
15.
Linder, Marie, et al.. (2015). Positive Association between Height and Cancer in the Swedish Population. 84. 2 indexed citations
16.
Kieler, Helle, et al.. (2015). Children with hemodynamically significant congenital heart disease can be identified through population-based registers. Clinical Epidemiology. 7. 119–119. 9 indexed citations
17.
Bröms, Gabriella, Fredrik Granath, Marie Linder, et al.. (2014). Birth Outcomes in Women with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 20(6). 1–1. 136 indexed citations
18.
Linder, Marie, et al.. (2012). Intrauterine death of a child with Goldenhar syndrome: a case presentation and review of the literature. Archives of Gynecology and Obstetrics. 286(3). 809–810. 2 indexed citations
19.
Bröms, Gabriella, Fredrik Granath, Marie Linder, et al.. (2012). Complications From Inflammatory Bowel Disease During Pregnancy and Delivery. Clinical Gastroenterology and Hepatology. 10(11). 1246–1252. 54 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stein Bergan Breakdown of academic impact, for papers by Masayuki Hashiguchi Breakdown of academic impact, for papers by S. E. Tett Breakdown of academic impact, for papers by Sarah Clarke Breakdown of academic impact, for papers by Christian Laveille Breakdown of academic impact, for papers by MO Karlsson Breakdown of academic impact, for papers by Xinqi Cheng Breakdown of academic impact, for papers by Wooseong Huh Breakdown of academic impact, for papers by Federica Braga Breakdown of academic impact, for papers by Simon de Denus
Rankless by CCL
2026